Triple

T4949174
Position Surface form Disambiguated ID Type / Status
Subject Fosun International E111125 entity
Predicate subsidiary P258 FINISHED
Object Fosun Pharma E483513 NE FINISHED

How this triple was built (2 steps)

Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.

NER Named-entity recognition gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: Fosun Pharma | Statement: [Fosun International, subsidiary, Fosun Pharma]
NED1 Entity disambiguation (via context triple) gpt-5-mini-2025-08-07
Target entity: Fosun Pharma
Context triple: [Fosun International, subsidiary, Fosun Pharma]
  • A. Fosun Pharma chosen
    Fosun Pharma is a major Chinese pharmaceutical and healthcare company engaged in the research, development, manufacturing, and distribution of a wide range of medical products and services.
  • B. Fosun International
    Fosun International is a major Chinese multinational conglomerate with diversified investments spanning sectors such as finance, healthcare, tourism, and consumer products.
  • C. Chugai Pharmaceutical
    Chugai Pharmaceutical is a major Japanese research-based pharmaceutical company known for its innovative biopharmaceuticals and strategic alliance with Roche.
  • D. Sinopharm
    Sinopharm is a Chinese state-owned pharmaceutical company best known globally for developing and distributing inactivated COVID-19 vaccines.
  • E. Takeda Pharmaceutical Company
    Takeda Pharmaceutical Company is a leading global biopharmaceutical firm headquartered in Japan, focused on developing innovative medicines in areas such as oncology, gastroenterology, neuroscience, and rare diseases.
  • F. None of above.
  • G. Unsure - the case is ambiguous/there is not enough information to decide.

Provenance (3 batches)

The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.

Step Stage Batch ID Status When
creating Elicitation batch_69bd441721cc819085c7e33fe0876818 completed March 20, 2026, 12:56 p.m.
NER Named-entity recognition batch_69bd7166bb6c8190a40775ac8bb723a8 completed March 20, 2026, 4:10 p.m.
NED1 Entity disambiguation (via context triple) batch_69be89eefa5c8190871debbb8fe6dabe completed March 21, 2026, 12:07 p.m.
Created at: March 20, 2026, 1:31 p.m.